111 related articles for article (PubMed ID: 7919349)
21. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome.
Robertson LE; Plunkett W; McConnell K; Keating MJ; McDonnell TJ
Leukemia; 1996 Mar; 10(3):456-9. PubMed ID: 8642861
[TBL] [Abstract][Full Text] [Related]
22. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
[TBL] [Abstract][Full Text] [Related]
23. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
Pedersen IM; Kitada S; Leoni LM; Zapata JM; Karras JG; Tsukada N; Kipps TJ; Choi YS; Bennett F; Reed JC
Blood; 2002 Sep; 100(5):1795-801. PubMed ID: 12176902
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
Jewell AP
Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
[TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo.
Jewell AP; Worman CP; Lydyard PM; Yong KL; Giles FJ; Goldstone AH
Br J Haematol; 1994 Oct; 88(2):268-74. PubMed ID: 7803269
[TBL] [Abstract][Full Text] [Related]
26. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
Battle TE; Arbiser J; Frank DA
Blood; 2005 Jul; 106(2):690-7. PubMed ID: 15802533
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.
de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A
Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901
[TBL] [Abstract][Full Text] [Related]
29. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
[TBL] [Abstract][Full Text] [Related]
30. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
33. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.
Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H
Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286
[TBL] [Abstract][Full Text] [Related]
34. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Willimott S; Baou M; Naresh K; Wagner SD
Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
[TBL] [Abstract][Full Text] [Related]
35. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
[TBL] [Abstract][Full Text] [Related]
36. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
[TBL] [Abstract][Full Text] [Related]
38. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
39. Gamma-linolenic acid induces apoptosis in B-chronic lymphocytic leukaemia cells in vitro.
Mainou-Fowler T; Proctor SJ; Dickinson AM
Leuk Lymphoma; 2001 Jan; 40(3-4):393-403. PubMed ID: 11426562
[TBL] [Abstract][Full Text] [Related]
40. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
